Insulin-mediated sympathoexcitation in obesity and type 2 diabetes

被引：4
|
作者：
Muntzel, MS [1 ]
机构：
[1] CUNY Herbert H Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 10期
关键词：
diabetes; hypertension; insulin; obesity; sympathetic nervous system;
D O I：
10.1093/ndt/14.10.2282
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2282 / 2285
页数：4
相关论文
共 50 条
  • [31] Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
    Zatterale, Federica
    Longo, Michele
    Naderi, Jamal
    Raciti, Gregory Alexander
    Desiderio, Antonella
    Miele, Claudia
    Beguinot, Francesco
    FRONTIERS IN PHYSIOLOGY, 2020, 10
  • [32] Obesity, Type 2 diabetes and metformin
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2017, 102 (09) : 869 - 869
  • [33] MicroRNAs and Type 2 Diabetes/Obesity
    Dehwah, Mustafa Abdo Saif
    Xu, Aimin
    Huang, Qingyang
    JOURNAL OF GENETICS AND GENOMICS, 2012, 39 (01) : 11 - 18
  • [34] MicroRNAs and Type 2 Diabetes/Obesity
    Mustafa Abdo Saif Dehwah
    Journal of Genetics and Genomics, 2012, (01) : 10 - 17
  • [35] Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
    Parkner, T.
    Dyrskog, S. E.
    Laursen, T.
    Chen, J. W.
    Mouritzen, U.
    Brondsted, L.
    Hermansen, K.
    Lauritzen, T.
    Christiansen, J. S.
    DIABETES OBESITY & METABOLISM, 2010, 12 (05) : 414 - 420
  • [36] Obesity in hospitalized type 2 diabetes patients: A descriptive study
    Blumentals, William A.
    Hwu, Peter
    Kobayashi, Norihiro
    Ogura, Eriko
    MEDICAL SCIENCE MONITOR, 2013, 19 : 359 - 365
  • [37] Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus
    Ramachandran, A
    Snehalatha, C
    Satyavani, K
    Sivasankari, S
    Vijay, V
    DIABETES OBESITY & METABOLISM, 2000, 2 (03) : 149 - 154
  • [38] The use of insulin in type 2 diabetes
    Matthews, DR
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S34 - S38
  • [39] Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
    Bellini, Lara
    Campana, Melanie
    Mahfouz, Rana
    Carlier, Aurelie
    Veret, Julien
    Magnan, Christophe
    Hajduch, Eric
    Le Stunff, Herve
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1037 - 1050
  • [40] Insulin therapy in type 2 diabetes
    Liebl A.
    Der Diabetologe, 2007, 3 (3): : 221 - 232
12345